HUE070250T2 - Nagy termelõképességû rekombináns kínai hörcsög petefészek-sejtvonal elõállítása terápiás fehérje termelésére - Google Patents

Nagy termelõképességû rekombináns kínai hörcsög petefészek-sejtvonal elõállítása terápiás fehérje termelésére

Info

Publication number
HUE070250T2
HUE070250T2 HUE21777795A HUE21777795A HUE070250T2 HU E070250 T2 HUE070250 T2 HU E070250T2 HU E21777795 A HUE21777795 A HU E21777795A HU E21777795 A HUE21777795 A HU E21777795A HU E070250 T2 HUE070250 T2 HU E070250T2
Authority
HU
Hungary
Prior art keywords
generation
cell line
chinese hamster
hamster ovary
therapeutic protein
Prior art date
Application number
HUE21777795A
Other languages
English (en)
Hungarian (hu)
Inventor
Bruno Louis Dumas
Mohammed Nabil Lounis
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of HUE070250T2 publication Critical patent/HUE070250T2/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0681Cells of the genital tract; Non-germinal cells from gonads
    • C12N5/0682Cells of the female genital tract, e.g. endometrium; Non-germinal cells from ovaries, e.g. ovarian follicle cells
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/87Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90Stable introduction of foreign DNA into chromosome
    • C12N15/902Stable introduction of foreign DNA into chromosome using homologous recombination
    • C12N15/907Stable introduction of foreign DNA into chromosome using homologous recombination in mammalian cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004Oxidoreductases (1.)
    • C12N9/001Oxidoreductases (1.) acting on the CH-CH group of donors (1.3)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/93Ligases (6)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y103/00Oxidoreductases acting on the CH-CH group of donors (1.3)
    • C12Y103/05Oxidoreductases acting on the CH-CH group of donors (1.3) with a quinone or related compound as acceptor (1.3.5)
    • C12Y103/05002Dihydroorotate dehydrogenase (1.3.5.2)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y603/00Ligases forming carbon-nitrogen bonds (6.3)
    • C12Y603/01Acid-ammonia (or amine)ligases (amide synthases)(6.3.1)
    • C12Y603/01002Glutamate-ammonia ligase (6.3.1.2)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/10Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/14Specific host cells or culture conditions, e.g. components, pH or temperature
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/30Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/31Immunoglobulins specific features characterized by aspects of specificity or valency multispecific
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/10Type of nucleic acid
    • C12N2310/20Type of nucleic acid involving clustered regularly interspaced short palindromic repeats [CRISPR]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Mycology (AREA)
  • Reproductive Health (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
HUE21777795A 2020-09-21 2021-09-21 Nagy termelõképességû rekombináns kínai hörcsög petefészek-sejtvonal elõállítása terápiás fehérje termelésére HUE070250T2 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP20306068 2020-09-21

Publications (1)

Publication Number Publication Date
HUE070250T2 true HUE070250T2 (hu) 2025-05-28

Family

ID=72840426

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE21777795A HUE070250T2 (hu) 2020-09-21 2021-09-21 Nagy termelõképességû rekombináns kínai hörcsög petefészek-sejtvonal elõállítása terápiás fehérje termelésére

Country Status (16)

Country Link
US (1) US20240043878A1 (https=)
EP (2) EP4214308B1 (https=)
JP (1) JP2023544267A (https=)
KR (1) KR20230068401A (https=)
CN (1) CN116457468A (https=)
AU (1) AU2021342718A1 (https=)
BR (1) BR112023005002A2 (https=)
CA (1) CA3195524A1 (https=)
ES (1) ES3010648T3 (https=)
HU (1) HUE070250T2 (https=)
IL (1) IL301442A (https=)
MX (1) MX2023003278A (https=)
PL (1) PL4214308T3 (https=)
TW (1) TWI912369B (https=)
WO (1) WO2022058603A1 (https=)
ZA (1) ZA202303597B (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12529071B2 (en) 2019-03-19 2026-01-20 Sanofi Selection marker-comprising cell line and uses thereof for protein production

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8717430D0 (en) 1987-07-23 1987-08-26 Celltech Ltd Recombinant dna product
KR100267720B1 (ko) 1997-12-29 2001-03-02 박호군 사람 글루타민 합성효소 유전자를 포함하는 발현벡터 및 이를 이용하여 동물세포에서 에리트로포이에틴을 고수율로 생산하는 방법
US20030166201A1 (en) * 2001-04-30 2003-09-04 Jensen Michael C. Selection systems for genetically modified cells
JP5756016B2 (ja) * 2008-10-29 2015-07-29 サンガモ バイオサイエンシーズ, インコーポレイテッド グルタミンシンセターゼ遺伝子の発現を不活性化する方法及び組成物
EP2674495A1 (en) * 2012-06-14 2013-12-18 Sanofi CHO expression system
AU2015334872B2 (en) * 2014-10-23 2021-12-16 Sanofi Novel selection marker for cell transfection and protein production
US12497624B2 (en) * 2018-07-13 2025-12-16 Lonza Ltd Methods for improving production of biological products by reducing the level of endogenous protein
WO2020012446A1 (en) * 2018-07-13 2020-01-16 Enzene Biosciences Limited Double knock-out cho cell line method of its generation and producing therapeutic proteins therefrom
US12529071B2 (en) * 2019-03-19 2026-01-20 Sanofi Selection marker-comprising cell line and uses thereof for protein production
WO2020243642A2 (en) * 2019-05-31 2020-12-03 The Trustees Of Columbia University In The City Of New York Multiply auxotrophic cell line for the production of recombinant proteins and methods thereof
CN110343668B (zh) * 2019-07-23 2021-11-19 珠海联邦制药股份有限公司 一种敲除gs基因的cho细胞株及其制备方法与应用

Also Published As

Publication number Publication date
IL301442A (en) 2023-05-01
MX2023003278A (es) 2023-04-12
EP4214308B1 (en) 2024-11-20
US20240043878A1 (en) 2024-02-08
AU2021342718A9 (en) 2025-03-27
CN116457468A (zh) 2023-07-18
KR20230068401A (ko) 2023-05-17
EP4214308A1 (en) 2023-07-26
PL4214308T3 (pl) 2025-04-14
TWI912369B (zh) 2026-01-21
ZA202303597B (en) 2024-08-28
BR112023005002A2 (pt) 2023-04-18
ES3010648T3 (en) 2025-04-04
WO2022058603A1 (en) 2022-03-24
AU2021342718A1 (en) 2023-06-08
TW202227622A (zh) 2022-07-16
JP2023544267A (ja) 2023-10-23
EP4541812A2 (en) 2025-04-23
CA3195524A1 (en) 2022-03-24
EP4541812A3 (en) 2025-06-11
EP4214308C0 (en) 2024-11-20

Similar Documents

Publication Publication Date Title
PL4214308T3 (pl) Wytwarzanie wysokoproduktywnej rekombinowanej linii komórek jajnika chomika chińskiego do wytwarzania białka terapeutycznego
EP4108633A4 (en) METHOD FOR PRODUCING LITHIUM HYDROXIDE
PH12021552108A1 (en) Methods of producing long acting ctp-modified growth hormone polypeptides
EP4140952A4 (en) Method for producing lithium hydroxide
MX2013001447A (es) Metodo de produccion y purificacion de una sialiltransferasa soluble activa.
HUE065497T2 (hu) Háromkamrás elektrolizáló cella alkálifém-alkoholátok elõállítására
GB201811785D0 (en) A continuous process for sustainable production of hydrogen
GB202308665D0 (en) Process for producing hydrogen
GB2625646B (en) Process for producing hydrogen
GB2625645B (en) Process for producing hydrogen
EP4508006A4 (en) Method for producing hydrogen using at least two biomethanes
EP4011825A4 (en) METHOD FOR PRODUCING SODIUM BOROHYDRIDE
PH12021551680A1 (en) Improved method for producing high purity lead
GB202213860D0 (en) Hydrogen production process
EP4129914A4 (en) METHOD FOR PRODUCING HALOGENIDES
EP3919506A4 (en) METHODS FOR PRODUCTION OF RECOMBINANT PROTEINS
EP4011826A4 (en) METHOD FOR PRODUCING SODIUM BOROHYDRIDE
EP3950927A4 (en) METHODS FOR PRODUCTION OF RECOMBINANT PROTEINS
GB202018320D0 (en) Methods of producing recombinant complement proteins
IL308405A (en) Transgenic cells to increase the production of proteins that are difficult to express
IN2014CN02982A (https=)
EP4497846A4 (en) HYDROGEN PRODUCTION SYSTEM
HK40090707A (en) Process for producing donor-batched cells expressing a recombinant receptor
IL319767A (en) Process for producing recombinant proteins
GB202308473D0 (en) Process for the production of recombinant proteins